- Activities: Diets and Dietary Modifications , Preceptor Series: Giving Difficult Feedback, Podcast: Medication Talk - Pharmacotherapy for Anxiety and Depression, Facilitating Discussions about Complementary and Alternative Therapies, Podcast: Medication Talk - Opioids: Strategies for Safe Use, Podcast: Medication Talk - Medication Safety Across Healthcare Teams, Sterile Compounding: Basics of USP Chapter 797, Sterile Compounding: Using Aseptic Technique, Nonsterile Compounding of Oral Liquid Preparations and Topicals, Nonsterile Compounding of Topical Dosage Forms, Podcast: Medication Talk Diabetes Treatment Updates, Controlled Substance Diversion Prevention & Management, Controlled Substance Inventory and Disposal, Controlled Substance Dispensing, Controlled Substance Prescriptions, Prescriber Insights CME-in-the-Letter September 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter September 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter September 2024, Pharmacy Technician's Letter CE-in-the-Letter September 2024, Canadian Pharmacist's Letter CE-in-the-Letter September 2024, Hospital Pharmacist's Letter CE-in-the-Letter September 2024, Pharmacist's Letter CE-in-the-Letter September 2024, Prescriber Insights CME-in-the-Letter August 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter August 2024, Canadian Pharmacist's Letter CE-in-the-Letter August 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter August 2024, Hospital Pharmacist's Letter CE-in-the-Letter August 2024, Pharmacy Technician's Letter CE-in-the-Letter August 2024, Pharmacist's Letter CE-in-the-Letter August 2024, Naloxone for Opioid Rescue, Prescriber Insights CME-in-the-Letter July 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter July 2024, Canadian Pharmacist's Letter CE-in-the-Letter July 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter July 2024, Hospital Pharmacist's Letter CE-in-the-Letter July 2024, Pharmacy Technician's Letter CE-in-the-Letter July 2024, Pharmacist's Letter CE-in-the-Letter July 2024, Controlled Substance Diversion Prevention in West Virginia, Medication Adherence, Podcast: Medication Talk Meds for Obesity and Weight Loss, Prescriber Insights CME-in-the-Letter June 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter June 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter June 2024, Pharmacy Technician's Letter CE-in-the-Letter June 2024, Canadian Pharmacist's Letter CE-in-the-Letter June 2024, Hospital Pharmacist's Letter CE-in-the-Letter June 2024, Pharmacist's Letter CE-in-the-Letter June 2024, Prescriber Insights CME-in-the-Letter May 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter May 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter May 2024, Pharmacy Technician's Letter CE-in-the-Letter May 2024, Canadian Pharmacist's Letter CE-in-the-Letter May 2024, Hospital Pharmacist's Letter CE-in-the-Letter May 2024, Pharmacist's Letter CE-in-the-Letter May 2024, Prescriber Insights CME-in-the-Letter April 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter April 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter April 2024, Pharmacy Technician's Letter CE-in-the-Letter April 2024, Canadian Pharmacist's Letter CE-in-the-Letter April 2024, Hospital Pharmacist's Letter CE-in-the-Letter April 2024, Pharmacist's Letter CE-in-the-Letter April 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter March 2024, Canadian Pharmacist's Letter CE-in-the-Letter March 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter March 2024, Hospital Pharmacist's Letter CE-in-the-Letter March 2024, Pharmacy Technician's Letter CE-in-the-Letter March 2024, Prescriber Insights CME-in-the-Letter March 2024, Pharmacist's Letter CE-in-the-Letter March 2024, Canadian Pharmacy Technician's Letter CE-in-the-Letter February 2024, Canadian Pharmacist's Letter CE-in-the-Letter February 2024, Hospital Pharmacy Technician's Letter CE-in-the-Letter February 2024, Hospital Pharmacist's Letter CE-in-the-Letter February 2024, Pharmacy Technician's Letter CE-in-the-Letter February 2024, Prescriber Insights CME-in-the-Letter February 2024, Pharmacist's Letter CE-in-the-Letter February 2024, Dyslipidemia Treatment, Atrial Fibrillation Management, Drug Supply Chain, High Blood Pressure Treatment, Heart Failure Management, Hospital Pharmacy Technician's Letter CE-in-the-Letter January 2024, Hospital Pharmacist's Letter CE-in-the-Letter January 2024, Pharmacy Technician's Letter CE-in-the-Letter January 2024, Podcast: Medication Talk First-Line Meds for Hypertension, Introduction to Atrial Fibrillation, Podcast: Medication Talk –Vaccine FAQs, Women's Reproductive Health, Acute Coronary Syndrome: Secondary Prevention, Ethical Issues in the Pharmacy, Hormonal Contraceptive Selection, Podcast: Medication Talk – Managing Chronic Coronary Disease, Podcast: Medication Talk – Flu Vaccine Updates, Podcast: Medication Talk – RSV Vaccines in Older Adults, Introduction to Acute Coronary Syndrome, Podcast: Medication Talk – Addressing Social Determinants of Health, Podcast: Medication Talk - Debate about LDL Targets, Coronary Heart Disease in Women: Treatment, Coronary Heart Disease in Women: Prevention, Coronary Heart Disease in Women: Clinical Presentation, Telehealth and Telephone Communication, Diabetes and Stroke, Diabetic Hypoglycemia: Causes, Treatment, and Prevention, Diabetic Hypoglycemia: Risk Factors and Symptoms, Pathophysiology of Diabetic Hypoglycemia, Podcast: Medication Talk – Buprenorphine for Opioid Use Disorder, Pharmacy Technician Roles and Responsibilities, Ethical Considerations in Pharmacy Law, Diabetes Self-management: Medication Teaching, Diabetes Self-management: Nondrug Interventions, Introduction to Diabetes Self-management, Diabetes Complications, Podcast: Medication Talk – First-Line Meds for Type 2 Diabetes, Injectable Diabetes Meds, Oral Diabetes Medication Review, Diabetes Epidemiology and Pathophysiology, Inpatient Management of Diabetes and Hyperglycemia, Neonatal Pharmacotherapy, Podcast: Medication Talk – New Opioid Guidelines, Just Culture and Error Reporting, USP 800 and Hazardous Meds, Quality Measures in Pharmacy Practice, Canadian Pharmacist's Letter CE-in-the-Letter March 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter December 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter November 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter October 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter September 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter August 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter July 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter June 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter May 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter April 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter March 2023, Canadian Pharmacy Technician's Letter CE-in-the-Letter February 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter December 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter November 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter October 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter September 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter August 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter June 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter May 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter April 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter March 2023, Hospital Pharmacy Technician's Letter CE-in-the-Letter February 2023, Pharmacy Technicians Letter CE-in-the-Letter December 2023, Pharmacy Technicians Letter CE-in-the-Letter November 2023, Pharmacy Technicians Letter CE-in-the-Letter October 2023, Pharmacy Technicians Letter CE-in-the-Letter September 2023, Pharmacy Technicians Letter CE-in-the-Letter August 2023, Pharmacy Technicians Letter CE-in-the-Letter June 2023, Pharmacy Technicians Letter CE-in-the-Letter April 2023, Pharmacy Technicians Letter CE-in-the-Letter March 2023, Pharmacy Technicians Letter CE-in-the-Letter February 2023, Canadian Pharmacist's Letter CE-in-the-Letter December 2023, Canadian Pharmacist's Letter CE-in-the-Letter November 2023, Canadian Pharmacist's Letter CE-in-the-Letter October 2023, Canadian Pharmacist's Letter CE-in-the-Letter September 2023, Canadian Pharmacist's Letter CE-in-the-Letter August 2023, Canadian Pharmacist's Letter CE-in-the-Letter July 2023, Canadian Pharmacist's Letter CE-in-the-Letter June 2023, Canadian Pharmacist's Letter CE-in-the-Letter May 2023, Canadian Pharmacist's Letter CE-in-the-Letter April 2023, Canadian Pharmacist's Letter CE-in-the-Letter February 2023, Hospital Pharmacist's Letter CE-in-the-Letter December 2023, Hospital Pharmacist's Letter CE-in-the-Letter November 2023, Hospital Pharmacist's Letter CE-in-the-Letter October 2023, Hospital Pharmacist's Letter CE-in-the-Letter September 2023, Hospital Pharmacist's Letter CE-in-the-Letter August 2023, Hospital Pharmacist's Letter CE-in-the-Letter July 2023, Hospital Pharmacist's Letter CE-in-the-Letter June 2023, Hospital Pharmacist's Letter CE-in-the-Letter May 2023, Hospital Pharmacist's Letter CE-in-the-Letter April 2023, Hospital Pharmacist's Letter CE-in-the-Letter March 2023, Hospital Pharmacist's Letter CE-in-the-Letter February 2023, Pharmacist's Letter CE-in-the-Letter December 2023, Pharmacist's Letter CE-in-the-Letter November 2023, Pharmacist's Letter CE-in-the-Letter October 2023, Pharmacist's Letter CE-in-the-Letter September 2023, Pharmacist's Letter CE-in-the-Letter August 2023, Pharmacist's Letter CE-in-the-Letter July 2023, Pharmacist's Letter CE-in-the-Letter June 2023, Pharmacist's Letter CE-in-the-Letter May 2023, Pharmacist's Letter CE-in-the-Letter April 2023, Pharmacist's Letter CE-in-the-Letter March 2023, Pharmacist's Letter CE-in-the-Letter February 2023, Responding to a Code Blue, Conflict Prevention and Management, Federal Pharmacy Law Review, Medication Management in Kidney Disease, Psoriasis Treatment Review, Specialty Medication Overview, Agitation, Sedation, and Delirium in Adult ICU Patients, Injectable Medication Administration for Technicians, Natural Psychedelics: A Trip Worth Taking?, Pharmacy-Administered Injectable Medications, Prevention and Treatment of Stroke, Complementary Therapies for Menopause, Maternal Safety Standards, Preventing Errors with High-Alert Medications, Identification and Management of Drug Allergies, Empathetic Care in the Pharmacy, Successful MTM Programs in Community Pharmacy, Getting to the Point: Acupuncture & Acupoint Therapies, Overview of Controlled Substances for Technicians, Asthma and Allergies: Symptoms and Treatment, Outpatient Therapies for COVID-19, Anticoagulation in Special Populations Part 2, Anticoagulation in Special Populations Part 1, Anticoagulation Reversal, Strategies for VTE Prophylaxis and Considerations in Special Populations, Periprocedural Anticoagulation Management, Management of Heparin-Induced Thrombocytopenia (HIT), Anticoagulation in Heart Failure and Mechanical Circulatory Support, Anticoagulation in Valvular Heart Disease, Thrombolytic Therapy for Pulmonary Embolism and Acute Ischemic Stroke, Anticoagulation for Atrial Fibrillation and Other Atrial Arrhythmias, NPSG Anticoagulation 2019: Overview and Strategies for Compliance, Anticoagulation Stewardship: Program Development and Interventions, Overview of Anticoagulants, Natural Medicines: Commonly Abused Supplements, Sterilization by Filtration, Steam and Dry-Heat Sterilization Methods, Bacterial Endotoxin Testing, Sterility Testing Requirements of USP Chapters 71 and 797, Use of Supplies and Components, Cleaning of Secondary Engineering Controls for Sterile Compounding, Cleaning of Primary Engineering Controls for Sterile Compounding, Sterile Compounding Environments Principles of Cleaning and Disinfection, Investigation and Remediation of Viable Environmental Monitoring and Personnel Sampling Excursions, Viable Air and Surface Sampling, Overview of Environmental Monitoring, Personnel Competency Testing in Aseptic Manipulation, Hand Hygiene and Garbing for Sterile Compounding, USP 797 Secondary Engineering Controls, USP 797 Primary Engineering Controls, Nonsterile Compounding for Animals, Staff Training and Competency for Nonsterile Compounding, Quality Control and Release Testing in a Nonsterile Compounding Practice, Packaging and Documentation of Nonsterile Formulations, Beyond-Use Dating (BUD) and Chemical Stability of Nonsterile Compounds, Nonsterile Compounding Process, Nonsterile Compounding Equipment, Component Selection, Receipt, Handling, and Storage, Responsibilities of the Compounder and Compounding Facility Requirements, Mathematics Review and Pharmaceutical Excipients, Introduction to Nonsterile Pharmacy Compounding, Building Proficiency in Sterile Compounding Calculations, Building Proficiency Calculations Required for Dilution and Reconstitution, Building Proficiency in Performing Calculations Required for Dosing, Percents and Concentrations, Basic Mathematical Concepts 2: Ratios, Proportions, and Percents, Basic Mathematical Concepts 1: Roman Numerals, Fractions, and Decimals, Measurement Systems, Introduction to Calculations, Fundamental Math Skills for Pharmacy Practice, Transitions of Care in Pain Management, Patients with Opioid Use Disorder, Perioperative Pain Management, Acute Pain Management in Opioid Tolerant Patients, Acute Pain Management in Opioid Tolerant Patients, Managing Pain: Unique Patients, Palliative Care, and the Emergency Department, Opioid Conversions and Equianalgesic Dosing, Leveraging Data, IT, and Clinical Decision Support in Opioid Stewardship, Getting Started: Helpful Resources for Implementing a Stewardship Program, The Case for Opioid Stewardship, Foundations in Pain Assessment, Expectations, and Multimodal Analgesia, Ratio and Proportion Calculations, Safely Dispensing Warfarin, Essential Skills for Leaders, Treatment of Sepsis and Catheter-Related Bloodstream Infections, Antimicrobial Stewardship of Clostridioides difficile Infection, Antifungal Treatment Approaches for Invasive Fungal Infections, Best Practices for the Treatment of Bone and Joint Infections, Diagnosis and Management of Urinary Tract Infections, Pharmacologic Management of Intra-abdominal Infections, Treatment Approaches for Lower Respiratory Tract Infections, Management of CNS Infections in the Immunocompetent Host, Skin and Soft Tissue Infections, Approaches in the Management of Antibiotic-resistant Bacterial Infections, Getting to the Core of Antimicrobial Stewardship, Fertility Treatment and Counseling, Microbiome Medley: Pre-, Pro-, and Postbiotics, Top-Selling Herbal Supplements, Medication Error Prevention in Special Populations & Situations, Strategies for Preventing Data Entry Errors, Rapid Point-of-Care Testing in the Community Setting, What are CGMPs? (21 CFR 211), Understanding FDA Forms and Other Relevant Documents, Review of FDA 503B Draft and Final Guidance, Insanitary Conditions, History Leading Up to 503B, Quality Assurance and Complaint Handling, Stability, Beyond-Use Dating, and Labeling, Sterility Testing, Endotoxin Testing, and other Final-Release Considerations, Overview of Methods of Sterilization (Filtration, Steam, Dry Heat, and Radiation), Development of Media Fills/Operator Qualifications and Process Validation, Environmental Monitoring, Hand Hygiene, Garbing, and Personnel Sampling, Aseptic Processing and Conduct in Controlled Environments, Designing an Effective Cleaning Program and Mechanisms to Evaluate Effectiveness, Primary and Secondary Engineering Controls, Surgery Suite Medications, The Scoop on Collagen, Texas Pharmacy Laws for Technicians, The Pharmacy Technician’s Role in the Prevention and Management of HIV, Stimulants in Adult Patients, Cannabinoid Overview, Opioid Safety, Intro to Pediatric Pharmacy, Understanding Glucosamine and Chondroitin, Communicating With the Healthcare Team, USP 800 Nonsterile Compounding Work Practice Strategies, Recognizing and Treating Post-Traumatic Stress Disorder (PTSD), HD Work Practice Decontamination and Spill Management (USP 795 and 797), HD Work Practice: Receiving Through Transport to Patients (USP 795 and 797), Personal Protective Equipment for HD Handling for USP 795 and 797 Compounding, Containment Primary & Secondary Engineering Controls (USP 795 and 797), Hazardous Drug Overview (USP 795 and 797), Best Practices for Mixing Outside of ISO-Classified Conditions (USP 797), Aseptic Technique and Conduct for Sterile Compounding, Best Practices for USP 797 Material Handling, Quality Management of Sterile Compounding, Use of Equipment and Integrating Technology for Sterile Compounding, General Elements of Documentation for Sterile Compounding, Standard Operating Procedures for Sterile Compounding, Master Formulation and Compounding Records for Sterile Compounding, USP 797 CSP Handling: Staging Through Transport, Quality Releases and Final Checks for Sterile Compounding, Determining USP 797 Beyond-Use Dating, History of Sterile Compounding, Strategies to Prevent Healthcare-Associated Infections, West Virginia Controlled Substance Diversion Prevention, Hypertension Management, Parenteral Nutrition for the Pharmacists, Rheumatoid Arthritis Treatment Review
- Provider Ship: 1
- Provider Address: Denver, CO, USA
- Activity Link: https://trchealthcare.com/
- Number of Activities Reported Last Year: 821
- Name of Contact: Flora Harp
- Phone Number: (209) 472-2240
- Address: 1720 S. Bellaire St., Suite 1250, Denver, CO, 80222, USA
- Accreditation Status: Joint Accreditation
- Accredited Provider: Joint Accreditation
- Activity Format: Enduring Material, Journal CME/CE, Live Course
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply